Eurofins CDMO Alphora Inc.: federal grants and contributions

Updated 12 October 2026 · Mississauga|Mississauga, ON · grants and contributions register · Mississauga–Lakeshore

Eurofins CDMO Alphora Inc.: federal grants and contributions: 4 agreements; $23.1M value; 2 departments; 3 programs.

Assay record ASY-CA-0VFLD9P1KK · Cite as: Assay Systems, “Eurofins CDMO Alphora Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/eurofins-cdmo-alphora-inc/

$
4agreements
$23.1Mvalue
2departments
3programs

Largest agreements

CDMO Biologics Development and Manufacturing operation$22.4Mvalue2023start2046end

This project will support the establishment of a biomanufacturing and development facility that is focused on mammalian cell culture. The facility will manufacture and produce antibody-based therapeutics and other protein biologics.

UK Biomanufacturing - 10136110 - NextGen ADC Platform-Engineering High-Yielding Expression Vectors and Peptide Linker Tags for Advanced ADC Production$500Kvalue2025start2027end

“As part of the international consortium project “NextGen ADC Platform: Engineering High-Yielding Expression Vectors and Peptide Linker Tags for Advanced ADC Production”, this project will aim to develop a novel expression platform for high-level production of monoclonal antibodies (mAbs) with optimized affinity peptide tags for development of advanced antibody drug conjugates (ADCs). This innovative approach eliminates the need for extra conjugation and purification steps, reducing the complexity and cost of ADC production and ultimately produces ADCs that can be reconstituted in the clinic,

Continuous Flow (CF) technology in manufacture and commercialization of API(s) and advanced intermediates for pharmaceutical market.$150Kvalue2025start2026end

This project consists of implementation of Continuous Flow technology into manufacturing processes for production of pharmaceutical materials (e.g. active pharmaceutical ingredients,). The project objectives are to intensify manufacturing processes, improve safety, and reduce manufacturing costs and carbon footprints.

Canada–UK Biomanufacturing Peer to Peer In Person Networking Meetings – June 2026$5.0Kvalue2026start2026end

Participation in Canada–UK biomanufacturing peer-to-peer networking meetings – June 8 to 15, 2026. Through the 2023 Canada–UK Biomanufacturing Initiative (Memorandum of Cooperation), Canada and the United Kingdom committed to advancing collaboration in biomanufacturing, with a focus on co-innovation, workforce development, and scale-up. The initiative includes the creation of a bilateral peer-to-peer network that brings together experts and organizations from both countries to strengthen partnerships and pursue shared growth opportunities.

Departments

Innovation, Science and Economic Development Canada1agreements$22.4Mvalue1programs
National Research Council Canada3agreements$655Kvalue2programs
  • Industrial Research Assistance Program – Contributions to Firms
  • Industrial Research Assistance Program

All grants from National Research Council Canada

Years

20261agreements$5.0Kvalue1programs
  • Industrial Research Assistance Program
20252agreements$650Kvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms
20231agreements$22.4Mvalue1programs
  • SIF Stream2- Growth

Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.